The Position of Pranlukast, a Cysteinyl Leukotriene Receptor Antagonist, in the Long-Term Treatment of Asthma

By  

Respiration, Vol. 71, Iss. 3, 2004-05 ,pp. : 225-232

Karger

Access to resources Recommend Favorite

Pranlukast, a Cysteinyl Leukotriene Type 1 Receptor Antagonist, Attenuates the Progression but Not the Onset of Silica-Induced Pulmonary Fibrosis in Mice

By  

International Archives of Allergy and Immunology, Vol. 158, Iss. 3, 2012-02 ,pp. : 241-251

Karger

Access to resources Recommend Favorite

Pranlukast, a Leukotriene Receptor Antagonist, Inhibits Interleukin-5 Production via a Mechanism Distinct from Leukotriene Receptor Antagonism

By  

International Archives of Allergy and Immunology, Vol. 136, Iss. 2, 2005-02 ,pp. : 165-172

Karger

Access to resources Recommend Favorite

Notch signaling mediates granulocyte‐macrophage colony‐stimulating factor priming‐induced transendothelial migration of human eosinophils

By  

ALLERGY, Vol. 70, Iss. 7, 2015-07 ,pp. : 805-812

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of a Cysteinyl Leukotriene Dual 1/2 Receptor Antagonist on Antigen-Induced Airway Hypersensitivity and Airway Inflammation in a Guinea Pig Asthma Model

By  

International Archives of Allergy and Immunology, Vol. 155, Iss. 1, 2011-06 ,pp. : 90-95

Karger

Access to resources Recommend Favorite